Nutrileads has won a prestigious Eurostars grant to support the development of its lead ingredient IMPP-1 for application in medical foods.
Nutrileads (as consortium leader) and 4 partners from the Netherlands, Germany and Finland have been awarded a € 2 million Eurostars project called NIMF. The consortium will develop Nutrileads’ proprietary ingredient Immune Modulatory Plant Polysaccharide-1 (IMPP-1) into a new ingredient for medical food products to fight impaired immune functioning as a result of malnutrition (particularly common in a variety of patient groups).
Nutrileads is developing this ingredient, in addition to medical food products, also for other food applications like dietary supplements and functional food.
The NIMF project was the highest rated project with a Dutch participant, ranking 4th of 269 applications across all fields in Europe. Erik Dam, CBO of NutriLeads emphasizes: “The very positive evaluation of the NIMF project provides a further validation of the relevance of our proposition and the quality of our science, team and partners”.
NutriLeads took part in the Venture Challenge Fall 2013.